Asana, Inc.
8.25USD
-0.5400 (-6.14%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.08▼ | $0.09 | 0 | 10 |
| Next quarter | $0.09▼ | $0.1 | 0 | 9 |
| Current year | $0.37▼ | $0.37 | 8 | 2 |
| Next year | $0.45▼ | $0.47 | 0 | 1 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-07-31 | $0.09 | $0.1 | +0.01 (+14.3%) |
| 2026-04-30 | $0.08 | $0.1 | +0.02 (+33.2%) |
| 2026-01-31 | $0.07 | $0.08 | +0.01 (+13.2%) |
| 2025-10-31 | $0.06 | $0.08 | +0.02 (+29.3%) |
224 ratings from 23 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| DA Davidson | Maintained | Neutral | $8 $9 | Sep 4, 2026 |
| Baird | Maintained | Neutral | $9 $10 | Sep 4, 2026 |
| RBC Capital | Maintained | Sector Perform | $8 $9.5 | Sep 4, 2026 |
| UBS | Maintained | Neutral | $8 $10 | Sep 4, 2026 |
| Citizens | Reiterated | Market Outperform | $15 | Sep 4, 2026 |
| BTIG | Reiterated | Neutral | — | Sep 4, 2026 |
| Piper Sandler | Maintained | Neutral | $7 $9 | Sep 4, 2026 |
| Citizens | Reiterated | Market Outperform | $15 | Jul 7, 2026 |
| DA Davidson | Maintained | Neutral | $8 | May 29, 2026 |
| Citigroup | Maintained | Buy | $13 $11 | May 29, 2026 |
| RBC Capital | Maintained | Sector Perform | $7 $8 | May 29, 2026 |
| Citizens | Reiterated | Market Outperform | $15 | May 29, 2026 |
| Keybanc | Maintained | Overweight | $15 $13 | May 29, 2026 |
| Morgan Stanley | Maintained | Underweight | $8 $7 | May 29, 2026 |
| Piper Sandler | Downgraded from Overweight | Neutral | $9 $7 | Apr 14, 2026 |
| RBC Capital | Upgraded from Underperform | Sector Perform | $7 | Apr 1, 2026 |
| UBS | Maintained | Neutral | $16 $9 | Mar 3, 2026 |
| Citigroup | Maintained | Buy | $16 $13 | Mar 3, 2026 |
| Morgan Stanley | Maintained | Underweight | $14 $8 | Mar 3, 2026 |
| RBC Capital | Maintained | Underperform | $11 $7 | Mar 3, 2026 |
| Keybanc | Maintained | Overweight | $18 $15 | Mar 3, 2026 |
| Baird | Maintained | Neutral | $16 $9 | Mar 3, 2026 |
| Piper Sandler | Maintained | Overweight | $14 $9 | Mar 3, 2026 |
| Jefferies | Maintained | Hold | $15 $8 | Feb 23, 2026 |
| Piper Sandler | Maintained | Overweight | $19 $14 | Feb 3, 2026 |
142 filings from 16 insiders · 18 buy / 15 sell over 6m
Officers and directors of ASAN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| ROGERS DANIEL MARKChief Executive Officer | Sell | 1.7k | $10.00 | $17k | Aug 27, 2026 |
| ROGERS DANIEL MARKChief Executive Officer | Grant | 35.5k | — | — | Aug 26, 2026 |
| ANDERSON-COPPERMAN KRISTADirector | Grant | 1.8k | — | — | Aug 3, 2026 |
| ROSENSTEIN JUSTINDirector | Gift | 2.70M | — | — | Jun 30, 2026 |
| ROGERS DANIEL MARKChief Executive Officer | Sell | 13.8k | $6.90 | $95k | Jun 30, 2026 |
| COLENDICH KATIE MARIEGeneral Counsel | Sell | 5.2k | $6.68 | $35k | Jun 26, 2026 |
| MEGJI AZIZChief Financial Officer | Sell | 13.2k | $6.73 | $89k | Jun 24, 2026 |
| COLENDICH KATIE MARIEGeneral Counsel | Sell | 16.0k | $6.66 | $107k | Jun 24, 2026 |
| MEGJI AZIZChief Financial Officer | Sell | 31.7k | $6.65 | $211k | Jun 22, 2026 |
| ROGERS DANIEL MARKChief Executive Officer | Sell | 27.0k | $6.66 | $180k | Jun 22, 2026 |
| SOSA VERONICAOfficer | Sell | 11.4k | $6.66 | $76k | Jun 22, 2026 |
| ROGERS DANIEL MARKChief Executive Officer | Grant | 654.7k | — | — | Jun 17, 2026 |
| BORODITSKY MARCDirector | Grant | 22.4k | — | — | Jun 8, 2026 |
| ROSENSTEIN JUSTINDirector | Grant | 22.4k | — | — | Jun 8, 2026 |
| LINDSAY ANDREWDirector | Grant | 22.4k | — | — | Jun 8, 2026 |
| CAREY SYDNEY LISADirector | Grant | 22.4k | — | — | Jun 8, 2026 |
| ANDERSON-COPPERMAN KRISTADirector | Grant | 22.4k | — | — | Jun 8, 2026 |
| MEGJI AZIZChief Financial Officer | Grant | 585.8k | — | — | May 6, 2026 |
| COLENDICH KATIE MARIEGeneral Counsel | Grant | 98.2k | — | — | May 6, 2026 |
| COHLER MATTHEW RDirector | Grant | 1.3k | — | — | May 1, 2026 |
No analyst notes on ASAN yet.
Analyst Ratings
13 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 4 | 8 | 2 | 0 | Hold2.73 |
| 1 mo ago | 1 | 4 | 8 | 2 | 0 | Hold2.73 |
| 2 mo ago | 1 | 4 | 8 | 2 | 0 | Hold2.73 |
| 3 mo ago | 1 | 4 | 8 | 2 | 0 | Hold2.73 |